Priming the pancreatic cancer tumor microenvironment for checkpoint-inhibitor immunotherapy.

Lutz, Eric R; Kinkead, Heather; Jaffee, Elizabeth M; Zheng, Lei

Lutz, Eric R; Kinkead, Heather; Jaffee, Elizabeth M; Zheng, Lei.

Afiliación

Lutz ER; Department of Oncology; Johns Hopkins University School of Medicine ; Baltimore, MD USA ; The Sidney Kimmel Cancer Center; Johns Hopkins University School of Medicine , Baltimore, MD USA ; The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care; Johns Hopkins University School of Med
Kinkead H; Department of Oncology; Johns Hopkins University School of Medicine ; Baltimore, MD USA ; The Sidney Kimmel Cancer Center; Johns Hopkins University School of Medicine , Baltimore, MD USA ; The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care; Johns Hopkins University School of Med
Jaffee EM; Department of Oncology; Johns Hopkins University School of Medicine ; Baltimore, MD USA ; The Sidney Kimmel Cancer Center; Johns Hopkins University School of Medicine , Baltimore, MD USA ; The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care; Johns Hopkins University School of Med
Zheng L; Department of Oncology; Johns Hopkins University School of Medicine ; Baltimore, MD USA ; The Sidney Kimmel Cancer Center; Johns Hopkins University School of Medicine , Baltimore, MD USA ; The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care; Johns Hopkins University School of Med

Oncoimmunology ; 3(11): e962401, 2014 Nov.

Article en En | MEDLINE | ID: mdl-25941589

Palabras clave

pancreatic cancer; tumor immunotherapy; tumor vaccines

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncoimmunology Año: 2014 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google